Intrathecal drug delivery for the management of pain and spasticity in adults: An executive summary of the British Pain Society’s recommendations for best clinical practice

British Journal of Pain

Volumn 10, Issue 2, 2016, Pages 67-69

  Duarte, Rui ^a   Raphael, Jon ^b   Eldabe, Sam ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Analgesia; Chronic pain; Intrathecal; Nociceptors; Pain

Indexed keywords

ARTICLE; CANCER PAIN; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG STABILITY; EPIDURAL ABSCESS; INTRATHECAL DRUG ADMINISTRATION; NEUROLOGIC DISEASE; PAIN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUMP; RESPIRATION DEPRESSION; SPASTICITY; WOUND INFECTION;

EID: 84981363547     PISSN: 20494637     EISSN: 20494645     Source Type: Journal    
DOI: 10.1177/2049463715587747     Document Type: Article

References (7)

1. Raphael JH, Duarte RV, Southall JL, et al. Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic noncancer pain. BMJ Open 2013; 3(7): e003061.
2. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20(19): 4040-4049.
3. Coffey RJ, Owens ML, Broste SK, et al. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain. Anesthesiology 2009; 111(4): 881-891.
4. Follett KA and Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000; 19(3): 209-215.
5. Duarte RV, Raphael JH, Sparkes E, et al. Long-term intrathecal drug administration for chronic non-malignant pain. J Neurosurg Anesthesiol 2012; 24(1): 63-70.
6. Deer TR, Levy R, Prager J, et al. Polyanalgesic Consensus Conference-2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation 2012; 15(5): 467-482.
7. Turner JA, Sears JM and Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain 2007; 23(2): 180-195.